by admin | Sep 12, 2017 | Uncategorized
Thanks to a whistleblower, the makers of the EpiPen will pay the Government $465 million to resolve claims that they falsely classified the drug as generic so that they could decrease the rebates they had to pay to Medicaid. A pharmaceutical company called...
by admin | May 11, 2017 | Uncategorized
On April 25, 2017, DOJ announced that a durable medical equipment (DME) provider would be paying $11.4 million in the face of allegations that it had provided home oxygen equipment to patients without getting a doctor’s approval. The Government also said that Pacific...
by admin | May 8, 2017 | Uncategorized
A Maryland company wound up paying $10.3 million under the False Claims Act to resolve allegations that it double billed Medicare for splints. According to DOJ, Dynasplint Systems, Inc., was submitting claims for splints for patients who were in skilled nursing...
by admin | May 4, 2017 | Uncategorized
College healthcare programs beware: the University of California says that its students were paid or tricked into handing over their student healthcare identification information. Scammers then bilked the school system of $12 million for bogus, unnecessary...
